10654 results
Edith N. Nyangoma, Christine K. Olson, Stephen R. Benoit, John Bos, Chas DeBolt, Meagan Kay, Krista Rietberg, Azadeh Tasslimi, Douglas Baker, Xinwen Feng, Susan Lippold, Sena Blumensaadt, Christopher Schembri, Arnold Vang, Heather Burke, Gregory Wallace,, Weigong Zhou
On July 5, 2013, CDC was notified of two cases of laboratory-confirmed measles in recently adopted children from an orphanage in Henan Province, China. To find potentially exposed persons, CDC...
Adam L. Cohen, Negar Aliabadi , Fatima Serhan, Jacqueline E. Tate, Patrick Zuber, Umesh D. Parashar
Vaccine has published a supplement entitled “Rotavirus Surveillance, Safety, and Economic Data before Vaccine Introduction: a Global Perspective from the World Health Organization Global Rotavirus...
Ed Clarke, Yauba Saidu, Jane U. Adetifa, Ikechukwu Adigweme, Mariama Badjie Hydara , Adedapo O. Bashorun , Ngozi Moneke-Anyanwoke, Ama Umesi, Elishia Roberts, Pa Modou Cham, Michael E. Okoye, Kevin E. Brown, Matthias Niedrig , Panchali Roy Chowdhury, Ralf Clemens, Ananda S. Bandyopadhyay, Jenny Mueller, David J. Jeffries, Beate Kampmann
Background The introduction of the inactivated poliovirus vaccine (IPV) represents a crucial step in the polio eradication endgame. This trial examined the safety and immunogenicity of IPV given...
Walter Ebile Akoh, Jerome Ateudjieu, Julienne Stephanie Nouetchognou, Martin Ndinakie Yakum , Fabrice Djouma Nembot, Sonia Nafack Sonkeng , Micheal Saah Fopa, Pierre Watcho
BACKGROUND: Vaccination is the most effective intervention strategy, and the provision of vaccination at fixed posts and outreach posts is a backbone of a sustainable vaccination system in...
E. Usuf, G. Mackenzie, Y. Lowe-Jallow, B. Boye, D. Atherly, C. Suraratdecha, U.K. Griffiths
The Gambia introduced seven-valent pneumococcal conjugate vaccine (PCV) in August 2009 and switched to 13-valent PCV in April 2011. In April 2009, monovalent hepatitis B and combined...
E. Leuridan, M. Sabbe, P. Van Damme
As women vaccinated against measles transfer low amounts of antibodies, an increasing number of infants lack early protection through maternal antibodies until being immunised themselves. This...
E. Colzani, S. A. McDonald, P. Carrillo-Santisteve, M. C. Busana, P. Lopalco, A. Cassini
Challenges in reaching good vaccination coverage against measles emerged in several European Union/European Economic Area Member States (EU/EEA MS) leading to progressive accumulation of susceptible...
E. Anis, E. Kopel, S. R. Singer, E. Kaliner, L. Moerman, J. Moran-Gilad, D. Sofer, Y. Manor, L. M. Shulman, E. Mendelson, M. Gdalevich, B. Lev, R. Gamzu, I. Grotto
The last widespread circulation of wild poliovirus in Israel was 25 years ago, resulting in a national outbreak with cases of permanent paralytic polio [3]. The major difference between the 1988...
Edwin J. Asturias, Ananda S. Bandyopadhyay, Steve Self, Luis Rivera, Xavier Saez-Llorens, Eduardo López, Mario Melgar, James T. Gaensbauer, William C. Weldon, Steven Oberste, Bhavesh R. Borate, Chris Gast, Ralf Clemens, Walter Orenstein, Miguel O'Ryan G. , José Jimeno , Sue Ann Costa Clemens , Joel Ward, Ricardo Rüttimann
Background Replacement of the trivalent oral poliovirus vaccine (tOPV) with bivalent types 1 and 3 oral poliovirus vaccine (bOPV) and global introduction of inactivated poliovirus vaccine (IPV) are...
Lotty Evertje Duijzer, Willem van Jaarsveld, Rommert Dekker
Vaccination is one of the most effective ways to prevent and/or control the outbreak of infectious diseases. This medical intervention also brings about many logistical questions. In the past years,...
Philippe Duclos, Stephanie Ortynsky, Nihal Abeysinghe, Niyazi Cakmak, Cara Bess Janusz, Barbara Jauregui, Richard Mihigo, Liudmila Mosina, Nahad Sadr-Azodi, Yashohiro Takashima, Laure Dumolard, Marta Gacic-Dobo
The majority of industrialized and some developing countries have established technical advisory bodies to guide and formulate national immunization policies and strategies. These are referred to as...
Ève Dubé, Dominique Gagnon, Emily Nickels, Stanley Jeram, Melanie Schuster
The term vaccine hesitancy refers to delay in acceptance or refusal of vaccines despite the availability of vaccination services. Different factors influence vaccine hesitancy and these are...
E. Nijsten, P. Carrillo-Santisteve, A. Miglietta, J. Ruitenberg, P. L. Lopalco
The WHO European Region has been declared polio-free since 2002. By 2010, inactivated polio vaccine (IPV) was the only polio vaccine in use in the EU/EEA for the primary vaccination of children. A...
Catherine Yen, Terri B. Hyde, Alejandro J. Costa, Katya Fernandez, John S. Tam, Stéphane Hugonnet, Anne M. Huvos, Philippe Duclos, Vance J. Dietz, Brenton T. Burkholder
Global vaccine stockpiles, in which vaccines are reserved for use when needed for emergencies or supply shortages, have effectively provided countries with the capacity for rapid response to...
Don L. Douglas, Denise A. DeRoeck, Richard T. Mahoney, Ole Wichmann
A face-to-face survey of 158 policymakers and other influential professionals was conducted in eight dengue-endemic countries in Asia (India, Sri Lanka, Thailand, Vietnam) and Latin America (Brazil,...
Dorothy Leab, Benjamin Schreiber, Musonda Kasonde, Olivia Bessat, Son Bui, Carine Loisel
This journal article presents key findings from a survey of 43 countries about the status of NLWGs. The study was conducted by the WHO-UNICEF Immunization Supply Chain Hub.
Renáta Dóró, Brigitta László, Vito Martella, Eyal Leshem, Jon Gentsch, Umesh Parashar, Krisztián Bányai
Comprehensive reviews of pre licensure rotavirus strain prevalence data indicated the global importance of six rotavirus genotypes, G1P[8], G2P[4], G3P[8], G4P[8], G9P[8] and G12P[8]. Since 2006, two...
Scott A. Halperin, Li Li, Donna MacKinnon-Cameron, Joanne M. Langley, Beth A. Halperin, Donna M. MacDougall
In Canada, rotavirus vaccine is recommended for all infants, but not all provinces/territories have publicly funded programs. The researchers compared public and healthcare provider (HCP) knowledge,...
Donata Medaglini, Magdalena R De Azero, Odile Leroy, Florence Bietrix, Philippe Denoel
A clear vision for vaccines research and development (R&D) is needed if Europe is to continue to lead the discovery of next generation vaccines. Innovation Partnership for a Roadmap on Vaccines in...
Donald P. Francis, Yu-Ping Du, Alexander R. Precioso
Hallmarks in the remarkable evolution of vaccines and their application include the eradication of smallpox, the development and delivery of the early childhood vaccines and the emergence of...
Matthieu Domenech de Cellès, Felicia M. G. Magpantay , Aaron A. King, Pejman Rohani
Pertussis, a highly contagious respiratory infection, remains a public health priority despite the availability of vaccines for 70 years. Still a leading cause of mortality in developing countries,...
Dina Balabanova, Anne Mills, Lesong Conteh, Baktygul Akkazieva, Hailom Banteyerga, Umakant Dash, Lucy Gilson, Andrew Harmer, Ainura Ibraimova, Ziaul Islam, Aklilu Kidanu, Tracey P. Koehlmoos, Supon Limwattananon, V. R. Muraleedharan, Gulgun Murzalieva, Benjamin Palafox, Warisa Panichkriangkrai, Walaiporn Patcharanarumol, Loveday Penn-Kekana , Timothy Powell-Jackson, Viroj Tangcharoensathien, Martin McKee
In 1985, the Rockefeller Foundation published Good health at low cost to discuss why some countries or regions achieve better health and social outcomes than do others at a similar level of income...
Dilip Singh Mairembam, Suchitra Lisam, Rajani Ved, Jhimly Barua, Prankul Goel, Roli Srivastava, Tushar Mokashi
Meghalaya, a hilly tribal state in northeast India, has many inaccessible areas with little or no access to good quality health services. With an infant mortality rate (IMR) of 58 infant deaths per...
Dilip Mathai, Abul Khair Mohammad Shamsuzzaman, Ahrar Ahmed Feroz, Amin R. Virani , Ashfaq Hasan, K. L. Ravi Kumar, Khalid Ansari, Khandaker Atm Forhad Hossain, Mahesh Marda, M. A. Wahab Zubair, Mohammed Mukarram Ali, N. Ashraf, Riyaz Basha, Shaeq Mirza, Shafeeq Ahmed, Shamim Akhtar, Syed Mustafa Ashraf, Zahirul Haque
Respiratory tract infections are prevalent among Hajj pilgrims with pneumonia being a leading cause of hospitalization. Streptococcus pneumoniae is a common pathogen isolated from patients with...
Alexa Dierig, Marc Tebruegge, Uros Krivec, Ulrich Heininger, Nicole Ritz
The study concludes that immunisation policies regarding BCG vaccine exist in the majority of European countries. Indications for BCG immunisation varied considerably, likely reflecting national TB...
Dian L. Baker, Michelle T. Dang, May Ying, Rafael Diaz
Of 3 potential contributing factors to perceived barriers—nativity, socioeconomic position, and use of traditional Hmong health care (i.e., consulting shamans and herbalists)—the latter 2...
Devy M. Emperador, Daniel E. Velasquez, Concepción F. Estívariz, Ben Lopman, Baoming Jiang, Umesh Parashar, Abhijeet Anand, Khalequ Zaman
Trivalent oral poliovirus vaccine (tOPV) is known to interfere with monovalent rotavirus vaccine (RV1) immunogenicity. Interference with bivalent and monovalent OPV formulations, which will be...
Devendra Gnawali, Michael McQuestion, Andrew Carlson, Khongorzul Dari, Clifford Kamara, Helene Mambu-Ma-Disu, Jonas Mbwanque, Diana Kizza, Dana Silver, Eka Paatashvili
A goal of the Global Vaccine Action Plan, led by the World Health Organization, is country ownership by 2020, defined here as the point when a country fully finances its routine immunization program...
Deron C. Burton, Godfrey M. Bigogo, Allan O. Audi, John Williamson, Kenneth Munge, Jackline Wafula,, Dominic Ouma, Sammy Khagayi, Isaac Mugoya, James Mburu, Shadrack Muema, Evasius Bauni, Tahreni Bwanaali, Daniel R. Feikin, Peter M. Ochieng, Ondari D. Mogeni, George A. Otieno, Beatrice Olack, Tatu Kamau, Melissa K. Van Dyke, Robert Chen, Paddy Farrington, Joel M. Montgomery, Robert F. Breiman, J. Anthony G. Scott, Kayla F. Laserson
There is a theoretical risk of adverse events following immunization with a preservative-free, 2-dose vial formulation of 10-valent-pneumococcal conjugate vaccine (PCV10). We set out to measure this...
Derek W. Cain, Sergio E. Sanders, Michael M. Cunningham, Garnett Kelsoe
Aluminum adjuvants, commonly referred to as “alum,” are the most widespread immunostimulants in human vaccines. Although the mechanisms that promote humoral responses to alum-adsorbed antigens...
Derek Asuman, Charles Godfred Ackah, Ulrika Enemark
Childhood vaccination has been promoted as a global intervention aimed at improving child survival and health, through the reduction of vaccine preventable deaths. However, there exist significant...
Dennis Odai Laryea, Emmanuel Abbeyquaye Parbie, Ebenezer Frimpong
Background Childhood immunisation is a cost-effective activity in health. Immunisation of children has contributed to reducing child morbidity and mortality. In the last two decades, global deaths...
Dennis L. Chao, Elizabeth Halloran, Ira M. Longini
In October 2010, a virulent South Asian strain of El Tor cholera began to spread in Haiti. Interventions have included treatment of cases and improved sanitation. Use of cholera vaccines would likely...
Denise F. Lillvis, Anna Frick, Anna Kirkland
From 2011 to 2013, immunization proponents won significant legislative victories that tightened philosophical exemptions in Washington, Oregon, and California. Highlighting data on the high rates of...
Molly Sauer - 2023
image
Countries now have access to an unprecedented wave of new vaccine presentation and product options and alternative schedules, with more options in the pipeline. This expanding landscape provides an...
Delia Adelina Vlad, Mariana Mărdărescu, Cristina Petre, Ruxandra Neagu-Drăghicenoiu, Rodica Ungurianu, Sorin Petrea, Ana Maria Tudor, Alina Cibea, Carina Matei, Odette Chirilă, Alexandra Mărdărescu, Mihai Mitran
Background Increased vulnerability of HIV infected children to numerous other infections is an argument for vaccination protection. Lately, we have been facing diseases that can be prevented by...
Shelley L. Deeks, Gillian H. Lim, Mary Anne Simpson, Louise Gagné, Jonathan Gubbay, Erik Kristjanson, Cecilia Fung, Natasha S. Crowcroft
This investigation was done to assess vaccine effectiveness of one and two doses of the measles, mumps and rubella (MMR) vaccine during an outbreak of mumps in Ontario. The level of coverage...
Shirley Villadiego, Kate Bartholomew, Tina Lorenson, Debra D. Kristensen
This study captures the perspectives of stakeholders at multiple levels of the vaccine supply chain regarding their assessment of challenges with storing vaccines within recommended temperature...
Debajeet Choudhuri, Tanvir Huda, Evropi Theodoratou, Harish Nair, Lina Zgaga, Rachel Falconer, Ivana Luksic, Hope L. Johnson, Jian Shayne F. Zhang, Shams El Arifeen, Christopher B. Nelson, Ray Borrow, Harry Campbell, Igor Rudan
Meningococcal meningitis is a major cause of disease worldwide, with frequent epidemics particularly affecting an area of sub-Saharan Africa known as the “meningitis belt”. Neisseria meningitidis...
Cuauhtémoc , Alejandro Ruiz , Nelson De la Hoz Gomez, Fernando Alvis Guzman, De la Hoz Restrepo
Three highly effective vaccines are available to prevent human papillomavirus (HPV) infection, and they have been introduced in many countries around the world. This article describes advances and...
Dawit Gebreegziabiher, Kassu Desta , Girmay Desalegn, Rawleigh Howe, Markos Abebe
M. tuberculosis and helminth infection each affects one third of the world population. Helminth infections down regulate cell mediated immune responses and this may contribute to lower efficacy of...
Dawei Liu, Wendi Wu, Keli Li, Disha Xu, Jiakai Ye, Li Li, Huaqing Wang
Surveillance for adverse events following immunization (AEFI) is an important component of any national immunization program. In the People's Republic of China (China), a populous, middle-income...
David W. McCormick, Elizabeth M. Molyneux
Acute bacterial meningitis (ABM) is a major cause of illness and death in children in sub-Saharan Africa. Neisseria meningitidis is the most common cause of ABM in the meningitis belt (sub-Saharan...
David Sarley, Mustafa Mahmud, Jide Idris, Modele Osunkiyesi, Onome Dibosa-Osadolor, Peter Okebukola, Owens Wiwa
Nigeria is the most populous country in Africa and in 2012 was suffering some of the lowest vaccination rates in the World. A combination of factors had resulted in a dysfunctional immunization cold...
David N. Durrheim, Natasha S. Crowcroft, Peter M. Strebel
Tremendous progress has been made globally to reduce the contribution of measles to the burden of childhood deaths and measles cases have dramatically decreased with increased two dose...
David N. Fisman, Patrick Tang , Tanya Hauck , Susan Richardson , Steven J. Drews, Donald E. Low, Frances Jamieson
Pertussis continues to challenge medical professionals; recently described increases in incidence may be due to age-cohort effects, vaccine effectiveness, or changes in testing patterns. Toronto,...
Cameron Bell, Katherine M. Atkinson, Kumanan Wilson
Collection of timely and accurate immunization information is essential for effective immunization programs. Current immunization information systems have important limitations that impact the...
D. Scott LaMontagne, Sandhya Barge, Nga Thi Le, Emmanuel Mugisha, Mary E. Penny, Sanjay Gandhi, Amynah Janmohamed, Edward Kumakech, N. Rocio Mosqueira, Nghi Quy Nguyen, Proma Paul, Yuxiao Tang, Tran Hung Minh, Bella Patel Uttekar, Aisha O. Jumaan
The global burden of cervical cancer is large and is increasing and it disproportionately affects low-resource countries.In 2008 there were approximately 529 000 new cases and over 270 000 deaths, of...